Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 26-Aug-22 4:06 PM View:  | Vincerx Pharma, Inc. (LSAC) | 25-Aug-22 | Purchase | 11,600 | $1.65 | $19,138.80 | 41% 28.4K to 40.0K | |
| 26-Aug-22 4:06 PM View: | Vincerx Pharma, Inc. (LSAC) | 24-Aug-22 | Private Purchase | 18,400 | $1.65 | $30,299.30 | 184% 10.0K to 28.4K | |
| 04-Mar-22 5:55 PM View: | Quince Therapeutics, Inc. (QNCX) | 03-Mar-22 | Grant | 175,000 | -- | -- | 194% 90.0K to 265.0K | |
| 16-Nov-21 8:17 PM View: | Quince Therapeutics, Inc. (QNCX) | 16-Nov-21 | Option Exercise | 30,000 | $2.23 | $66,900.00 | 50% 60.0K to 90.0K | |
| 07-Oct-21 6:24 PM View: | Quince Therapeutics, Inc. (QNCX) | 05-Oct-21 | Option Exercise | 4,963 | $54.85 | $272,221.00 | 8% 60.0K to 64.96K | |
| 07-Oct-21 6:24 PM View: | Quince Therapeutics, Inc. (QNCX) | 05-Oct-21 | Market Option Sale (Planned) | 4,963 | $98.50 | $488,856.00 | (8%) 64.96K to 60.0K | |
| 18-Aug-21 5:25 PM View: | Quince Therapeutics, Inc. (QNCX) | 17-Aug-21 | Option Exercise | 30,000 | $2.23 | $66,900.00 | 100% 30.0K to 60.0K | |
| 18-Aug-21 5:25 PM View: | Quince Therapeutics, Inc. (QNCX) | 16-Aug-21 | Option Exercise | 22,000 | $2.23 | $49,060.00 | 73% 30.0K to 52.0K | |
| 18-Aug-21 5:25 PM View: | Quince Therapeutics, Inc. (QNCX) | 16-Aug-21 | Market Option Sale (Planned) | 22,000 | $95.31 | $2,096,780.00 | (42%) 52.0K to 30.0K | |
| 30-Jun-21 5:46 PM View: | Quince Therapeutics, Inc. (QNCX) | 30-Jun-21 | Option Exercise | 30,000 | $2.23 | $66,900.00 | 100% 0 to 30.0K | |
| 30-Jun-21 6:59 PM View: | Vincerx Pharma, Inc. (LSAC) | 30-Jun-21 | Private Purchase | 3,600 | $12.66 | $45,576.00 | 56% 6.4K to 10.0K | |
| 30-Jun-21 6:59 PM View: | Vincerx Pharma, Inc. (LSAC) | 29-Jun-21 | Private Purchase | 6,400 | $12.59 | $80,576.00 | 100% 0 to 6.4K | |
| 30-Jun-21 5:46 PM View: | Quince Therapeutics, Inc. (QNCX) | 28-Jun-21 | Option Exercise | 20,000 | $2.23 | $44,600.00 | 100% 0 to 20.0K | |
| 30-Jun-21 5:46 PM View: | Quince Therapeutics, Inc. (QNCX) | 28-Jun-21 | Market Option Sale (Planned) | 20,000 | $54.15 | $1,083,070.00 | (100%) 20.0K to 0 | |
| 29-Jul-16 8:28 PM View: | Hansen Medical, Inc. (HNSN) | 27-Jul-16 | Disposition | 104,250 | $4.00 | $417,000.00 | (100%) 104.25K to 0 | |
| 29-Jul-16 8:28 PM View: | Hansen Medical, Inc. (HNSN) | 27-Jul-16 | Option Exercise | 100,000 | -- | -- | 2353% 4.25K to 104.25K | |
| 20-May-14 7:40 PM View: | Hansen Medical, Inc. (HNSN) | 20-May-14 | Market Purchase | 20,000 | $1.44 | $28,890.00 | 89% 22.5K to 42.5K | (72%) |
| 15-May-13 4:35 PM View: | Hansen Medical, Inc. (HNSN) | 13-May-13 | Market Purchase | 12,500 | $1.52 | $19,000.00 | 125% 10.0K to 22.5K | (74%) |
| 27-Mar-13 9:20 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 25-Mar-13 | Grant | 67,579 | -- | -- | 163% 41.34K to 108.92K | |
| 07-Jan-13 9:17 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 03-Jan-13 | Payment of Exercise | 8,660 | $0.69 | $5,975.40 | (17%) 50.0K to 41.34K | 100% |
| 06-Feb-12 8:38 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 06-Feb-12 | Grant | 18,845 | -- | -- | 60% 31.15K to 50.0K | |
| 03-Feb-12 4:01 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 01-Feb-12 | Market Sale (Planned) | 15,000 | $7.66 | $114,900.00 | (33%) 46.15K to 31.15K | 100% |
| 04-Nov-11 8:24 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 03-Nov-11 | Market Sale | 15,000 | $6.88 | $103,236.00 | (25%) 61.15K to 46.15K | 100% |
| 27-Oct-11 7:48 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 25-Oct-11 | Market Sale | 4,637 | $7.07 | $32,783.60 | (7%) 65.79K to 61.15K | 100% |
| 09-Aug-11 6:21 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 08-Aug-11 | Option Exercise | 10,000 | $1.34 | $13,400.00 | 18% 55.79K to 65.79K | |
| 04-Aug-11 8:08 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 03-Aug-11 | Market Sale | 14,600 | $6.88 | $100,432.00 | (21%) 70.39K to 55.79K | 100% |
| 04-Aug-11 8:08 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 02-Aug-11 | Market Sale | 5,000 | $7.31 | $36,571.40 | (7%) 75.39K to 70.39K | 100% |
| 05-Jul-11 6:34 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 30-Jun-11 | Payment of Exercise | 23,500 | $8.17 | $191,995.00 | (24%) 98.89K to 75.39K | 100% |
| 22-Jun-11 8:11 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 21-Jun-11 | Option Exercise | 20,000 | $1.31 | $26,199.60 | 26% 77.28K to 97.28K | |
| 14-Feb-11 10:00 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 11-Feb-11 | Sale | 80,997 | -- | -- | (51%) 158.28K to 77.28K | |
| 24-Sep-10 9:20 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 24-Sep-10 | Market Purchase | 5,000 | $4.18 | $20,900.00 | 3% 148.16K to 153.16K | (100%) |
| 02-Jul-10 7:11 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 30-Jun-10 | Grant | 40,000 | -- | -- | 37% 108.16K to 148.16K | |
| 30-Apr-10 10:00 PM View: | Hansen Medical, Inc. (HNSN) | 30-Apr-10 | Market Purchase | 10,000 | $2.66 | $26,600.00 | 100% 0 to 10.0K | (85%) |
| 01-Apr-10 8:46 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 31-Mar-10 | Option Exercise | 9,637 | $0.22 | $2,155.22 | 10% 98.52K to 108.16K | |
| 05-Mar-10 7:03 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 04-Mar-10 | Conversion | 17,523 | -- | -- | 100% 17.52K to 35.05K | |
| 05-Mar-10 7:03 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 04-Mar-10 | Conversion | 80,997 | -- | -- | 231% 35.05K to 116.04K |